Sample rows from Pregnancy Related Diseases. Field types are labelled in each column heading.
#	TextID	TextDisease Name	TextCategory	TextPrevalence	TextInheritance Pattern	TextAffected Gene(s)	LocationChromosome Location	TextKey Symptoms	TextTypical Age of Onset	TextDiagnosis Methods	TextAvailable Treatments	TextOrphan Drug Designation	TextICD-10 Code	NumberOMIM Number	TextAffected System(s)	TextDisease Severity	TextLife Expectancy Impact
01	1	Chronic Hypertension in Pregnancy	Hypertensive Disorders	1-5% of pregnancies	Acquired / Multifactorial	N/A	N/A	BP >=140/90 before 20 weeks gestation or pre-pregnancy; often asymptomatic; headache, visual changes if severe	Pre-pregnancy or <20 weeks	Pre-pregnancy BP records; BP measurement <20 weeks; 24-hour ambulatory BP	Labetalol, nifedipine XL, methyldopa; low-dose aspirin 81 mg from 12 weeks for preeclampsia prevention	No	O10.919	N/A	Cardiovascular / Maternal	Moderate	Minimal with control
02	2	Gestational Hypertension	Hypertensive Disorders	6-17% of nulliparous pregnancies	Acquired / Multifactorial	N/A	N/A	New-onset BP >=140/90 after 20 weeks without proteinuria or end-organ dysfunction	After 20 weeks gestation	Serial BP measurements; urine protein; laboratory surveillance for progression	Labetalol, nifedipine; antenatal surveillance; delivery by 37 weeks	No	O13.9	N/A	Cardiovascular / Maternal	Moderate	Minimal with treatment
03	3	Preeclampsia without Severe Features	Hypertensive Disorders	3-5% of pregnancies	Acquired / Multifactorial	N/A	N/A	BP >=140/90 plus proteinuria (>=300 mg/24h) after 20 weeks; may have edema, mild headache	After 20 weeks gestation	BP measurement; urine protein:creatinine ratio; CBC, LFTs, creatinine; uric acid	Antihypertensives (labetalol, nifedipine); antenatal surveillance; delivery at 37 weeks	No	O14.00	N/A	Multi-system / Maternal-Fetal	Moderate to Severe	Reduced without treatment
04	4	Preeclampsia with Severe Features	Hypertensive Disorders	1-2% of pregnancies	Acquired / Multifactorial	N/A	N/A	BP >=160/110; severe headache, visual disturbance, RUQ pain, pulmonary edema, thrombocytopenia, elevated LFTs, oliguria	After 20 weeks gestation	BP criteria; CBC (platelets <100k); AST/ALT 2x ULN; creatinine >1.1; clinical symptoms	IV magnesium sulfate for seizure prophylaxis; IV labetalol/hydralazine/oral nifedipine; delivery at 34 weeks	No	O14.10	N/A	Multi-system / Maternal-Fetal	Severe	Reduced without treatment
05	5	HELLP Syndrome	Hypertensive Disorders	0.2-0.8% of pregnancies; 10-20% of severe preeclampsia	Acquired / Multifactorial	N/A	N/A	Hemolysis, elevated liver enzymes, low platelets; RUQ pain, nausea, malaise; may lack hypertension	Third trimester or postpartum (up to 7 days)	Peripheral smear (schistocytes); LDH >600; AST/ALT >2x ULN; platelets <100k; haptoglobin low	IV magnesium sulfate; BP control; corticosteroids; prompt delivery; platelet transfusion if <20k or bleeding	No	O14.20	N/A	Hepatic / Hematologic / Maternal	Severe	Reduced without treatment

Pregnancy Related Diseases

About this dataset

Data preview

Explore the sample

There’s more to discover.